ArticleChinese medicine2025
A novel algorithm- specific loci screening accelerates the establishment of molecular quantification of Glycyrrhiza glabra, G. uralensis, and G. inflata.
Article in Chinese medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveThis study aims to establish a specialized molecular method for distinguishing different licorice and quantifying target species accurately from mixtures.
methodsA rapid specific loci screening (SLS) algorithm was developed in this study, and used the chloroplast genome sequences were used to screen for variable loci in the Glycyrrhiza glabra (GG), G. uralensis (GU), and G. inflata (GI). Each locus has been validated by polymerase chain reaction and pyrosequencing. The selected loci were analyzed by Herb molecular quantification (Herb-Q) assay to complete the quantitative methodology verification and establish a quantitative detection system for homemade licorice mixtures and one of the patent medicines-Liuyi San.
resultsOutstanding performance was observed in quantitative validation, which evaluated linearity (0.9989), limit of detection (2%) and quantification (2%), and repeatability; additionally, a quantitative detection system was established for homemade licorice mixtures and Liuyi San (one of the patent medicines), with the lowest bias being 3.48%. When both GG and GU were present in the mixed powder, the average biases for GG and GU quantification were 8.25% and 8.01%, respectively. When only GG was present in Liuyi San, the bias was 6.43%; when both GG and GU were present, the biases for GG and GU were 5.61% and 3.48%, respectively.
conclusionThis study successfully established an accurate detection system for quantifying the botanical origin of edible-medicinal licorice, which represents a significant milestone in enhancing the safety, efficacy, and quality control in licorice products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.